Global Syringe and Needle Market

Global Syringe and Needle Market was valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 7.8% during a forecast period.

Market Definition

Syringes and Needles are sterile devices used to inject solutions into the body. Syringes and needles are also used to segregate various types of body fluids, such as tissues from joints and blood from veins.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Market Dynamics

The Research Report gives a detailed analysis of the drivers and restraints in the Syringe and Needle Market. The main factors boosting the growth of global syringe and needle market is growing government funding to support clinical trials, rising occurrence of chronic ailments, acceptance & demand for safety syringes and needles over conventional reusable syringes and needles, up surging geriatric population, partnerships between biopharma companies and CROs, and investments in R&D that are resulting from these partnerships. Key market players are conducting extensive research and development activities worldwide to introduce syringes and needles with maximum precision and safety, which in turn, is promoting the market demand.

Global Syringe and Needle Market Segment analysis

Based on Usability, the Disposable Syringe segment is expected to grow at a CAGR of 5.8% during the forecast period. The syringes that are used by clinicians only once to inject medicines for the treatment of diseases. These syringes and needles are cost-effective and are ready to use in a sterilized condition that reduces the chances of contamination and spread of infection to the patient. These syringes are aided in monitoring the spread of AIDS in individuals. The Disposable Syringe market is mostly driven by rising demand for these syringes for giving medication through intravenous or intramuscular ways for treating the diseases. Disposable syringe market is the wide market with huge potential because of the growing R&D for developing new chemicals that are used in the manufacturing of these syringes, and continuous clinical trials to also boosting market growth.

Global Syringe and Needle Market Regional analysis

The North America region has dominated the market with US$ XX% Mn in 2019 thanks to several government legislative improvements whose purpose is to provide regulatory guidelines to manufacturing companies. The initiatives are taken by various organizations aimed at the eradication of blood-borne infections propelling the growth of the market. According to the American Diabetes Association, the annual healthcare cost in the U.S. increased by 26% during the last five years due to increased diabetes incidences.

Besides, the growth in medical technology has facilitated the east availability of a different variety of needles and brought more specialization in the industry, consequently fueling market growth. For example, the U.S. needle stick safety and prevention Act provides specific regulatory guidelines to syringe and needle manufactures for the development of safety needles. The most important country-specific markets in this region are the United States of America (USA) and Canada.

Country-wise Analysis

Some macroeconomic factors and internal market forces will shape the growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America, and the Middle East which will grow at a CAGR of XX%.

Key Developments and Acquisitions

• In Apr 30th, 2019 B. Braun through their collaboration with Schreiner MediPharm, they launched the first FDA-approved prefilled heparin syringe with an integrated needle protection device.

• In April 24, 2019 — B. Braun Medical Inc. launched Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the United States.

• In sept. 10, 2019 - B. Braun Medical Inc launched of Onvision, a breakthrough ultrasound guidance solution for real-time needle tip tracking in regional anesthesia. Available on the latest version of the B. Braun and Philips Xperius ultrasound system, Onvision gives anesthesiologists the confidence to accurately position the needle tip inside the body.

The objective of the report is to present a comprehensive analysis of the Global Syringe and Needle Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Syringe and Needle Market dynamics, structure by analyzing the market segments and project the Global Syringe and Needle Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Syringe and Needle Market make the report investor’s guide.

Scope of the Global Syringe and Needle Market

Global Syringe and Needle Market, by Type

• Disposable Syringe And Needle

• Reusable Syringe And Needle

Global Syringe and Needle Market, by Application

• Cardiovascular

• Dental

• Diagnostic

• General Surgery

• Neurology

• Ophthalmology

• Orthopedics

• Respiratory

• Others

Global Syringe and Needle Market, by End-User

• Hospitals and Clinics

• Home Care

• Other

Global Syringe and Needle Market, by Regions

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East and Africa (MEA)

Key Players operating the Global Syringe and Needle Market

• Braun Medical

• Covidien

• Terumo

• Smith’s Medical

• Albert David

• Connecticut Hypodermics

• Alcon Laboratories Incorporated

• Becton, Dickinson & Company

• Light Medical Products Co., Ltd.

• Medtronic plc.

Fore More Information Visit https://www.maximizemarketresearch.com/market-report/global-syringe-and-needle-market/54138/Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [email protected]

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908 8989132284

 

[Dhruv Bindhani]

The provided text is an overview of a market research report on the Global Syringe and Needle Market, with a focus on its dynamics, segmentation, regional analysis, and competitive landscape. The report states the market was valued at US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, growing at a CAGR of 7.8% during the forecast period. While the exact numerical values for market size are redacted in the snippet, external data provides clearer figures for the broader syringes market (which includes needles). For instance, the global syringes market was valued at around USD 15.34 billion in 2019 and is projected to reach USD 32.39 billion by 2027, exhibiting a CAGR of 9.6% from 2020 to 2027.1

Market Definition and Dynamics​

Syringes and needles are essential sterile medical devices used for injecting solutions into the body and for collecting body fluids or tissues.2 The market's growth is primarily driven by several critical factors:

• Increasing Government Funding for Clinical Trials: This boosts the demand for various medical devices, including syringes and needles.
• Rising Incidence of Chronic Ailments: Diseases like diabetes, cancer, and cardiovascular disorders necessitate frequent injections for medication delivery and blood draws, directly increasing demand.
• Growing Acceptance and Demand for Safety Syringes and Needles: These are preferred over conventional reusable options due to their role in preventing needle-stick injuries and reducing the spread of infections.
• Upsurging Geriatric Population: The elderly population is more prone to chronic diseases and requires more frequent medical interventions, thus driving demand.3
  
  
• Partnerships between Biopharma Companies and CROs: These collaborations often lead to increased R&D activities, focusing on developing new and safer injection devices.
• Continuous R&D: Key market players are investing heavily in R&D to introduce syringes and needles with maximum precision and safety, further promoting market demand.4
  
  
• Impact of COVID-19: The pandemic significantly impacted the market, with increased demand for syringes and needles for vaccination programs and treatment of COVID-19 patients.5
  

Segment Analysis​

Based on usability, the Disposable Syringe segment is a significant growth area, projected to grow at a CAGR of 5.8%. Disposable syringes and needles are cost-effective, sterile, and ready-to-use, minimizing contamination and the risk of infection transmission (e.g., AIDS).6 Their demand is driven by the widespread need for intravenous and intramuscular medication administration, ongoing R&D for new manufacturing materials, and continuous clinical trials. Current trends indicate that safety syringes, a sub-segment of disposable syringes, are experiencing rapid growth due to increasing emphasis on preventing needlestick injuries.7 Prefilled syringes also show strong growth, offering convenience and precise dosing, especially for biologics and self-administration.8






The report also segments the market by Application (Cardiovascular, Dental, Diagnostic, General Surgery, Neurology, Ophthalmology, Orthopedics, Respiratory, Others) and End-User (Hospitals and Clinics, Home Care, Other), highlighting the diverse applications and demand centers. Hospitals and clinics remain the largest end-users due to high patient volume and comprehensive medical procedures.9

Regional Analysis​

North America has historically dominated the market, largely due to stringent government legislative improvements aimed at providing regulatory guidelines to manufacturing companies.10 Initiatives by various organizations to eradicate blood-borne infections further propel market growth.11 The high incidence of diabetes in the U.S., for example, significantly drives healthcare costs and the demand for related medical devices. The region also benefits from advanced medical technology and a well-developed healthcare infrastructure.





Emerging countries in Asia-Pacific, Latin America, and the Middle East are anticipated to exhibit strong growth, driven by macroeconomic factors and internal market forces. The Asia-Pacific syringe market, for instance, is projected to grow at a CAGR of over 9% from 2025-2030, owing to rising chronic and infectious diseases, mass vaccination programs, and increased manufacturing focus in the region.

Key Developments and Competitive Landscape​

The market is characterized by the presence of numerous key players, including:

• B. Braun Medical
• Covidien (now part of Medtronic)12
  
  
• Terumo13
  
  
• Smith’s Medical (now part of ICU Medical)14
  
  
• Albert David15
  
  
• Connecticut Hypodermics16
  
  
• Alcon Laboratories Incorporated17
  
  
• Becton, Dickinson & Company (BD)
• Light Medical Products Co., Ltd.
• Medtronic plc.

Recent key developments highlight the industry's focus on safety and innovation:

• April 30, 2019: B. Braun, in collaboration with Schreiner MediPharm, launched the first FDA-approved prefilled heparin syringe with an integrated needle protection device.18
  
  
• April 24, 2019: B. Braun Medical Inc. launched Heparin Sodium Injection, USP – the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with an attached safety needle in the U.S.
• September 10, 2019: B. Braun Medical Inc. launched Onvision, an ultrasound guidance solution for real-time needle tip tracking in regional anesthesia, in collaboration with Philips.

These developments underscore the continuous efforts by market leaders to enhance product precision, safety, and ease of use, which are critical factors influencing market demand and competition. The competitive landscape is also shaped by strategic alliances, mergers, and acquisitions, as companies strive to expand their product portfolios and geographical presence.19